Membrane filters (0.22-,um pore size) were colonized with 104 CFU of logarithmic-phase bacteria per filter under laminar flow conditions in a Modified Robbins Device. Colonized filters were then placed upon agar dilution plates for MIC determinations. Subsequently, filters were transferred to control plates and incubated to obtain MBCs.
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The biofilm mode of bacterial growth, with its sessile (adherent) phenotype, is common in diseases, e.g., device-related infections. Here it poses a major problem because of a phenotypic resistance to antimicrobial agents (6, 10, 15) . Despite its acknowledged importance, biofilm technology has not appeared yet in National Committee for Clinical Laboratory Standards (NCCLS) documentation.
As a result, susceptibility testing of surface-grown bacteria by nonclinical procedures has been described in the literature (5, 7, 11, 14, 16, 20) . Apart from not conforming to clinical guidelines, these methods do not distinguish between loosely adherent and firmly adherent populations. This is because no method involves the formation of colonies under laminar flow conditions, i.e., shear-inducing circumstances, after the attachment phase. This is a prerequisite for true biofilm development and represents the forces found within medical catheters in situ or in hemodynamic systems (6, 9) . The chemostat approach (3) does incorporate firmly adherent biofilms, but it is a valuable research tool rather than a method directly applicable to infectious diseases and clinical microbiology.
We describe an attempt to unite NCCLS guidelines and biofilm concepts with a view to promoting consideration of this philosophy in the clinical arena. The method incorporates both shear forces and testing by using NCCLS guidelines for MICs and MBCs (12, 13) . This parallels the well-regulated quantitative testing of antimicrobial susceptibilities of bacteria using the planktonic (nonadherent, i.e., floating or freely swimming bacteria grown in flasks or test tubes) phenotype commonly examined in clinical laboratories (8, 12, 13, 17 populations, was delivered through a sparger into the flask. Stirring was started, and at between 1.5 and 2.0 h later, a flow of logarithmic-phase bacteria (approximately 2 x 106 CFU ml-') was initiated at 300 ml h-over the filters.
In early experiments, the flow was stopped at selected time points and the level of filter colonization was determined by a modification of our disruption method (15) . Specimen plugs were removed and washed with 5 ml of sterile phosphatebuffered saline (PBS), pH 7.4, to displace planktonic bacteria. Replicate filters were removed, and each was placed in a sterile, 35-by-10-mm-diameter petri dish. To reduce static buildup, 20 pul of PBS was placed on each filter, which was then scraped and macerated thoroughly with a sterile scalpel. Scalpel blades and the contents of each plate were transferred with 10-ml PBS rinses to conical centrifuge tubes. These were sonicated on low power (5 min, 1.0 A, 50 to 60 Hz), (12) .
Postcolonization events are depicted in Fig. 3 . The planktonic population flowing over the specimen plugs was sampled for viable counts, broth dilution MICs and MBCs, and the agar dilution MICs described below. Only agar dilution MBCs of P-lactams are recognized for planktonic bacteria (13) biofilm theory (6) . This highlights the lack of biofilm-effective antimicrobial agents (3) , even for the American Type Culture Collection strains, and in this sense, the method emphasizes testing for antibiotic resistance (18) . Generally, MBC endpoints were not found with the agar dilution ranges employed in this pilot study, despite the misleadingly low MICs for the intact microcolonies. These low MICs reflected the nascent aspect of the biofilms, i.e., conforming to NCCLS guidelines, they were approximately 2 h old and not fully formed and consequently did not show elevated MICs (1, 15) .
With practice, establishing the inoculum density and the filter colonization rate became routine. Dark filters became available after the conclusion of experiments, and in limited tests, they appeared to be a worthwhile visual aid.
The approach with MRDs described here will be useful for the screening of novel compounds with biofilm activity. The approach could also include synergy testing against colonized filters in agar dilution checkerboards or those checkerboards incorporating antimicrobial agents and, e.g., biofilm-active proteases (19) . In a departure from clinical guidelines, extended colonization times could be used to produce "old" biofilms for determination of the biofilm eliminating concentration (1) . Importantly, the MRD method is to date the only one that can be used to investigate the enhancement by direct-current electric fields of the efficacy of antimicrobial agents against biofilms (2, 4) . Currently, agar dilution MBCs are recognized for ,-lactams only (13) . However, routine determinations of MBCs of other antibiotics against strictly planktonic bacteria are feasible by replacing multipoint inoculator transfer with membrane filter transfer (5, 11, 14) . Calibrated bacterial suspensions could be dropped onto filters, and after incubation on antibiotic agar, filters and their potential colonies could be transferred to control plates for MBC determinations.
The MRD approach described above probably would not become a routine test but rather a subspeciality-driven service in large diagnostic laboratories or in infectious disease projects. However, it brings closer together the concepts of bacterial biofilms and susceptibility testing by using clinical microbiology standards.
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